Contrary to some conservative reviews, cyber attacks pose a serious threat to pharmaceutical companies. They’re neither new nor small-scale. They’re not about to go away either.
Most recently, a well-recognized pharma manufacturer came into the spotlight in connection with a Petya malware attack, the severity of which was so high, it threatened the supply of some of its drugs.
It wasn’t the only one.
In October 2016, J&J warned diabetic patients of a data vulnerability with its insulin pump. The nature of the attack (hackers could break into the system and overdose patients) and its severity (low) differed.
Though not all pharma manufacturers have the scale and outreach that would attract data thieves, they do pose as attractive repositories of personal data —collected en massive and over time. For pharma companies–the message is clear—it’s never too soon to start investing in a robust data security system